Skip to main content
    K

    Kala Pharmaceuticals Inc (KALA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.56
    +3.42 (+2464.84%)

    Market Cap: $89,480

    Last updated: Nov 17, 2026 at 10:57 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(16/33)
    Avg Surprise
    -27.65%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-345.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio6.88xQuick Ratio6.88x
    Trading Statistics
    Beta-2.20Avg Volume222.35K
    52-Week High$2865.0052-Week Low$3.44

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 805.0% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 96.4, above 70, the overbought line.

    Moving Averages

    SMA 10$0.50
    SMA 20$0.34
    SMA 50$0.39
    SMA 200$5.20
    EMA 10$0.78
    EMA 20$0.51
    EMA 50$0.54
    EMA 200$25.69

    MACD

    Line: 0.22Signal: -0.01Hist: 0.23

    ADX

    ADX: 48.3+DI: 91.9-DI: 2.9

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down8.0
    PSAR$0.13

    Bollinger Bands

    Upper Band$1.86
    Lower Band$-1.17
    %B Position88540%(Upper)
    Band Width1.56

    RSI (14-Day)

    Overbought
    96.4

    Momentum Oscillators

    Stoch %K41.2
    Stoch %D34.6
    Williams %R-13.2
    ROC (10d)2029.2%
    Momentum3.39
    CCI (20d)666.7
    MFI (14d)43.7

    Volatility Measures

    ATR (14d)$0.31(8.7%)
    StdDev (20d)0.76
    Hist Vol8755.3%(High)

    Volume Flow

    VWAP$3.72
    OBV473.7M
    AD Line408.7B
    CMF (20d)-0.415

    Volume Metrics

    Avg Vol (20d)220.8K
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.19

    Pivot Points

    R3$0.17
    R2$0.16
    R1$0.15
    Pivot Point$0.14
    S1$0.13
    S2$0.12
    S3$0.11

    Advanced Oscillators

    TSI58.59
    Ultimate Osc84.0
    KST942.36

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about KALA

    News

    KALA Valuation

    KALA Profitability: Margins, ROIC and FCF

    Kala Pharmaceuticals (KALA) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -345.3%
    KALA financial statements

    Kala Pharmaceuticals Competitors

    The companies most similar to Kala Pharmaceuticals (KALA) include Karyopharm Therapeutics, Kalaris Therapeutics and Kiora Pharmaceuticals.

    Sector: Healthcare

    Companies most similar to Kala Pharmaceuticals

    KALA Bull Case vs Bear Case

    Bull case

    • KALA beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • KALA's quarterly revenue changed -100.0% year over year.

    KALA Earnings: Beat Rate

    Kala Pharmaceuticals (KALA) beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate (75.0%). Its next report is expected on Nov 17, 2026.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    28.8%
    KALA earnings history

    KALA Earnings Date

    KALA reports Nov 17, 2026. The date is estimated.

    See insider activity

    Updated Aug 19, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About KALA

    When does KALA report earnings?

    Kala Pharmaceuticals Inc (KALA) is expected to report earnings on Nov 17, 2026.

    Does KALA pay dividends?

    Kala Pharmaceuticals Inc (KALA) does not currently pay a regular dividend.

    What is KALA's market cap?

    Kala Pharmaceuticals Inc (KALA) has a market capitalization of $89,480 with a current stock price of $3.56.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.